Inflammatory Bowel Disease I: Ulcerative Colitis
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Hepatic Drug Excretion: Influencing Factors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 12, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Alexander Malik1, Muhammad N Yousaf2, Sami Samiullah3
1Department of Medicine, Summa Health System, Akron, OH, United States.
Simultaneous immune checkpoint inhibitor (ICI)-associated hepatitis and colitis is a rare but serious adverse event. Early recognition and prompt treatment are crucial for managing these overlapping toxicities in cancer patients.
Area of Science:
Background: